Catalyst Pharmaceuticals (CPRX) Current Assets (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Current Assets of $940.4 million for Q1 2026, up 37.14% year-on-year from $685.7 million in Q1 2025, and up 5.19% on a QoQ basis from $894.0 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Current Assets data on file, last reported at $940.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 37.14% year-over-year to $940.4 million; the trailing twelve-month figure through Mar 2026 stood at $940.4 million (up 37.14% YoY), and the FY2025 full-year result was $894.0 million, up 43.36% from the prior year.
- Current Assets for Q1 2026 stood at $940.4 million, up from $894.0 million in the prior quarter.
- Across five years, Current Assets topped out at $940.4 million in Q1 2026 and bottomed at $192.0 million in Q3 2023.
- The 5-year median for Current Assets is $404.6 million (2024), against an average of $475.6 million.
- The widest annual swing landed in 2023, when Current Assets sank 31.63%; it then jumped 184.33% in 2024.
- A 5-year view of Current Assets shows it stood at $320.8 million in 2022, then plunged by 31.63% to $219.3 million in 2023, then surged by 184.33% to $623.6 million in 2024, then soared by 43.36% to $894.0 million in 2025, then grew by 5.19% to $940.4 million in 2026.
- The last three Current Assets figures came in at $940.4 million (Q1 2026), $894.0 million (Q4 2025), and $852.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 940.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 940.39 Mn |
| Dec 31, 2025 | 894.03 Mn |
| Sep 30, 2025 | 852.45 Mn |
| Jun 30, 2025 | 758.74 Mn |
| Mar 31, 2025 | 685.72 Mn |
| Dec 31, 2024 | 623.61 Mn |
| Sep 30, 2024 | 539.00 Mn |
| Jun 30, 2024 | 474.43 Mn |
| Mar 31, 2024 | 404.60 Mn |
| Dec 31, 2023 | 219.33 Mn |
| Sep 30, 2023 | 192.02 Mn |
| Jun 30, 2023 | 240.97 Mn |
| Mar 31, 2023 | 198.91 Mn |
| Dec 31, 2022 | 320.81 Mn |
| Sep 30, 2022 | 276.31 Mn |
| Jun 30, 2022 | 242.56 Mn |
| Mar 31, 2022 | 221.19 Mn |
| Dec 31, 2021 | 210.11 Mn |
| Sep 30, 2021 | 192.80 Mn |
| Jun 30, 2021 | 176.31 Mn |
| Mar 31, 2021 | 161.53 Mn |
| Dec 31, 2020 | 159.24 Mn |
| Sep 30, 2020 | 143.34 Mn |
| Jun 30, 2020 | 131.16 Mn |
| Mar 31, 2020 | 116.94 Mn |
| Dec 31, 2019 | 111.36 Mn |
| Sep 30, 2019 | 90.58 Mn |
| Jun 30, 2019 | 72.06 Mn |
| Mar 31, 2019 | 54.86 Mn |
| Dec 31, 2018 | 55.19 Mn |
| Sep 30, 2018 | 62.48 Mn |
| Jun 30, 2018 | 69.09 Mn |
| Mar 31, 2018 | 78.94 Mn |
| Dec 31, 2017 | 85.19 Mn |
| Sep 30, 2017 | 34.42 Mn |
| Jun 30, 2017 | 35.75 Mn |
| Mar 31, 2017 | 37.46 Mn |
| Dec 31, 2016 | 41.45 Mn |
| Sep 30, 2016 | 45.06 Mn |
| Jun 30, 2016 | 48.67 Mn |
| Mar 31, 2016 | 53.48 Mn |
| Dec 31, 2015 | 59.90 Mn |
| Sep 30, 2015 | 64.36 Mn |
| Jun 30, 2015 | 68.26 Mn |
| Mar 31, 2015 | 75.97 Mn |
| Dec 31, 2014 | 43.83 Mn |
| Sep 30, 2014 | 45.76 Mn |
| Jun 30, 2014 | 45.86 Mn |
| Mar 31, 2014 | 22.17 Mn |
| Dec 31, 2013 | 25.32 Mn |
| Sep 30, 2013 | 28.64 Mn |
| Jun 30, 2013 | 12.48 Mn |
| Dec 31, 2012 | 16.73 Mn |
| Mar 31, 2012 | 4.97 Mn |
| Dec 31, 2011 | 6.23 Mn |
| Sep 30, 2011 | 4.27 Mn |
| Jun 30, 2011 | 5.57 Mn |
| Dec 31, 2010 | 5.78 Mn |